sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
23-Jul-2016 13:02
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1286.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 14-Jun-2016
Microbial Genomics
Genome sequencing helps determine end of tuberculosis outbreak
Using genome sequencing, researchers from the University of British Columbia, along with colleagues at the Imperial College in London, now have the ability to determine when a tuberculosis outbreak is over.

Contact: Katherine Came
katherine.came@ubc.ca
604-822-0530
University of British Columbia

Public Release: 14-Jun-2016
eLife
New plant engineering method could help fill demand for crucial malaria drug
A new and inexpensive technique for mass-producing the main ingredient in the most effective treatment for malaria, artemisinin, could help meet global demands for the drug, according to a study to be published in the journal eLife.
European Research Council, Max-Planck-Gesellschaft

Contact: Emily Packer
e.packer@elifesciences.org
eLife

Public Release: 13-Jun-2016
PLOS ONE
Topical application of antiretroviral drug combination prevents transmission of (S)HIV
Findings published last week in the journal PLOS ONE confirm that researchers from the Oak Crest Institute of Science have demonstrated for the first time that two powerful antiretroviral drugs can provide complete protection against HIV when delivered topically by a sustained release intravaginal ring (IVR) device. The combination of tenofovir disoproxil fumarate and emtricitabine delivered at independently controlled rates via the pod-IVR was successful at preventing SHIV162p3 infection for over four months.

Contact: Dr. Marc M. Baum
info@oak-crest.org
626-817-0883
Oak Crest Institute of Science

Public Release: 10-Jun-2016
FDA approves vaccine for cholera
In a milestone years in the making, a vaccine to prevent cholera was approved today by the FDA. The vaccine, Vaxchora, is the only approved vaccine in the US for protection against cholera.

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 10-Jun-2016
The Open Nursing Journal
An investigation of nurses' job satisfaction in a private hospital and its correlates
Job satisfaction and its impact on staff performance, absenteeism, retention, and turnovers in health care services has been a topic of global interest over decades.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 8-Jun-2016
npj Microgravity
Switched-on Salmonella: Fluid forces guide disease traits of multidrug-resistant bacteria
In new research appearing in the Nature Publishing Group journal npj Microgravity, Cheryl Nickerson, Ph.D., and her colleagues explore the effects of physiological fluid shear on ST313 -- a particularly dangerous type of Salmonella, which is resistant to multiple antibiotics and currently ravaging regions of sub-Saharan Africa.

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University

Public Release: 8-Jun-2016
Antimicrobial Agents and Chemotherapy
Modeling the correct doses for disease-fighting drugs
Publishing earlier this week in the American Society for Microbiology's Antimicrobial Agents and Chemotherapy, Brad Reisfeld, associate professor in Colorado State University's Department of Chemical and Biological Engineering, has described a new computational model for optimizing dosing for the tuberculosis drug Rifapentine.

Contact: Anne Ju Manning
anne.manning@colostate.edu
970-491-7099
Colorado State University

Public Release: 8-Jun-2016
Journal of Neuroscience
Metabolite of multiple sclerosis drug could be safe, effective therapy for Parkinson's disease
The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say.

Contact: Toni Baker
tbaker@augusta.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 7-Jun-2016
Proceedings of the National Academy of Sciences
Pneumococcal vaccine watches bacteria, strikes only when needed
Conventional vaccines indiscriminately destroy bacteria and other disease-causing agents. The approach works, but there is growing concern that it creates opportunity other pathogens to harm the body -- similar to antibiotic resistance resulting in new and more potent pathogens. A new, protein-based pneumococcal vaccine takes a different approach. It allows pneumonia-causing bacteria to colonize in the body and -- like a nightclub bouncer -- swings into action only if the bacteria becomes harmful.
National Institutes of Health, Swedish Medical Research Council, Arthur A. Schomburg Fellowship Program at the University at Buffalo

Contact: Cory Nealon
cmnealon@buffalo.edu
716-645-4614
University at Buffalo

Public Release: 7-Jun-2016
Biology Letters
Sexual transmission of Ebola likely to impact course of outbreaks
Sexual transmission of the Ebola virus could have a major impact on the dynamics of the disease, potentially reigniting an outbreak that has been contained by public health interventions, according to research by University of Georgia ecologists just published in the Royal Society journal Biology Letters. The potential for sexual transmission is high for three to four months after the virus has been cleared from the bloodstream, and possible for an average of seven months.
NIH/National Institute of General Medical Sciences, National Science Foundation

Contact: Stephanie Schupska
schupska@uga.edu
706-542-6927
University of Georgia

Public Release: 6-Jun-2016
Preventive Medicine
1 hour of driving a day = 2.3kg more weight and 1.5cm wider waist, study reveals
A research study led by Professor Takemi Sugiyama from the Australian Catholic University's Institute of Health and Ageing, show the convenience of car travel has a significant impact on public health.

Contact: Rajiv Maharaj
rajiv.maharaj@acu.edu.au
61-047-685-3461
Australian Catholic University

Public Release: 5-Jun-2016
GHIT Fund welcomes ten new partnerships
The Global Health Innovative Technology Fund today welcomed ten new funding partnerships that include major global pharmaceutical and biotechnology companies -- collaborations that will expand investments into research and development for neglected diseases worldwide, many of which have already begun to show progress in clinical trials.

Contact: Katy Lenard
klenard@burness.com
301-280-5719
Burness

Public Release: 2-Jun-2016
BMC Infectious Diseases
Low risk of dengue infection predicted for foreign visitors to Rio Olympics
Three months before the opening of the Rio de Janeiro Summer Olympics, a group of researchers at University of São Paulo's Medical School (FM-USP) used a mathematical model to calculate the risk of dengue acquisition by the 400,000-odd foreign visitors expected to attend. This model was used with success during the last FIFA World Cup, in 2014. Once again a very low number of dengue cases among foreign visitors to the Olympics is likely, according the study.
São Paulo Research Foundation

Contact: Samuel Antenor
samuel@fapesp.br
55-113-838-4381
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 2-Jun-2016
Lancet Infectious Diseases
New study finds that vaccinating mothers against flu can protect newborns
Each year, influenza causes between 250,000 and half a million deaths around the world. Now a new study has shown that immunizing mothers against flu can decrease by 70 percent the risk of their infants getting flu during the first four months after birth. This is the largest study so far to show that maternal vaccination against flu is feasible and effective in resource-poor environments.

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 2-Jun-2016
GigaScience
We've got tapeworms and scabies! And reproducible research
Two new research papers on scabies and tapeworms published in the Open Access journal GigaScience also include a collaboration with protocols.io. This collaboration showcases a new way to share scientific methods that allows scientists to better repeat and build on these complicated studies on difficult-to-study parasites. It also highlights a new means of writing all research papers with citable methods that can be updated over time. Keeping work clear, consistent, and current.

Contact: Scott Edmunds
Scott@gigasciencejournal.com
852-361-03531
GigaScience

Public Release: 1-Jun-2016
UAB developing training program on Ebola for first responders in Deep South
UAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.
NIH/National Institute of Environmental Health Sciences

Contact: Alicia Rohan
arohan@uab.edu
205-975-7515
University of Alabama at Birmingham

Public Release: 1-Jun-2016
PLOS ONE
17 million women/children tasked with household water collection in 24 African countries
Nearly 17 million women and children (mostly girls) in 24 sub-Saharan African countries are responsible for hauling water long distances to their homes, a task that takes them more than 30 minutes per trip, according to a study published today in the journal PLOS ONE.

Contact: Kathy Fackelmann
kfackelmann@gwu.edu
202-994-8354
George Washington University Milken Institute School of Public Health

Public Release: 31-May-2016
Risk of international spread of yellow fever re-assessed in light of the ongoing outbreaks
ECDC has updated its rapid risk assessment on the outbreak of yellow fever with the latest developments, more comprehensive information on the current situation in Angola, Democratic Republic of Congo (DRC) and Uganda and an extended threat assessment for the EU. Some of the data used in the assessment were collected during a mission to Angola in May 2016.

Contact: ECDC Press
press@ecdc.europa.eu
European Centre for Disease Prevention and Control (ECDC)

Public Release: 31-May-2016
Big Data
Novel type 2 diabetes risk model more accurately assesses disease trajectory
An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D. In addition to identifying a typical T2D trajectory, the new model has shown that people who follow atypical trajectories can face significantly increased or decreased risks of developing T2D, according to an article in Big Data.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 31-May-2016
PLOS Medicine
Large global range of prices for hepatitis C medicines raises concerns about affordability
The prices and affordability of recently developed and highly effective direct-acting antivirals for treating hepatitis C vary greatly among countries worldwide, according to a study published this week in PLOS Medicine.

Contact: PLOS Medicine
medicinepress@plos.org
PLOS

Public Release: 27-May-2016
PeerJ
Predicting the spread of the Zika virus
A new tool by Japan-based researchers predicts the risk of Zika virus importation and local transmission for 189 countries.
Japanese Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency, CREST program, RISTEX program

Contact: Hiroshi NISHIURA
nishiurah@med.hokudai.ac.jp
Hokkaido University

Public Release: 27-May-2016
COHESION: Fighting diseases affecting the world's most vulnerable population
Supported by the Swiss National Science Foundation and the Swiss Development Cooperation, the COHESION project -- which stands for COmmunity HEalth System InnovatiON -- aims to assess the current management of NTDs and NCDs in these countries, to understand its challenges and to develop country-specific interventions, in partnership with local stakeholders and taking into account cultural and gender issues.

Contact: Sarah Lachat
Sarah.Lachat@hcuge.ch
41-763-462-889
Université de Genève

Public Release: 27-May-2016
Cell Host & Microbe
How Zika infects the placenta
Zika can infect Hofbauer placental macrophages, and to a lesser degree, cytotrophoblasts. May explain how the virus crosses the placenta.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory Health Sciences

Public Release: 26-May-2016
UCSB receives Grand Challenges Explorations grant
Microbial geneticist David Low will lead a project conducting groundbreaking research in global health and development.
Bill and Melinda Gates Foundation

Contact: Julie Cohen
805-893-7220
University of California - Santa Barbara

Public Release: 26-May-2016
Trends in Immunology
Malnutrition results from more than just inadequate diet
Malnourished children are most likely to die from common infections, not starvation alone, and immune disorder may be part of the cause, according to a review led by Queen Mary University of London.
Wellcome Trust, UK Department for International Development, Medical Research Council, Bill and Melinda Gates Foundation

Contact: Joel Winston
j.winston@qmul.ac.uk
44-020-788-27943
Queen Mary University of London

Showing releases 76-100 out of 1286.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>